240 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy

Zorginstituut Nederland carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment of 5q Spinal ...

Report | 07-02-2018

Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia

Zorginstituut Nederland issued package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...

Report | 18-01-2018

Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis

Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...

Report | 04-01-2018

Zinnige Zorg room for improvement report - Chest pain (Suspected) Stable Angina Pectoris

Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be ...

Report | 17-12-2017

Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma

Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

Report | 07-12-2017

Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

Zorginstituut Nederland has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone (Raxone®) is not ...

Report | 20-10-2017

Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

Publication | 19-10-2017

Project: ‘ICHOM as an accelerator for outcome information’ - factsheet

Publication | 19-10-2017

Glycerol phenylbutyrate (Ravicti®) for the treatment of urea-cycle disorders

Zorginstituut Nederland has carried out an assessment of the medicinal product glycerol phenylbutyrate (Ravicti®) for the ...

Report | 12-09-2017

Zinnige Zorg room for improvement report - In-depth phase neoplasms: care during the final stage of life of patients with incurable intestinal or lung cancer

The final stage of life is one in which a patient is of an advanced age or has a disease and/or is in a phase of a disease that ...

Report | 01-09-2017